STOCK TITAN

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

CareDx (Nasdaq: CDNA), a company focused on transplant healthcare solutions, has announced it will release its fourth quarter and full year 2024 financial results after market close on Wednesday, February 26, 2025. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. Interested parties can access the call via phone using 1-800-267-6316 (domestic) or 1-203-518-9783 (international) with Conference ID: CareDx. A webcast will also be available through the Events & Presentations section of CareDx's Investor Relations website.

CareDx (Nasdaq: CDNA), un'azienda specializzata in soluzioni per la salute dei trapianti, ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato mercoledì 26 febbraio 2025. L'azienda ospiterà una conferenza telefonica alle 13:30 ora del Pacifico / 16:30 ora dell'Est nello stesso giorno. Le parti interessate possono accedere alla chiamata tramite telefono componendo il numero 1-800-267-6316 (domestico) o 1-203-518-9783 (internazionale) con ID Conferenza: CareDx. Sarà inoltre disponibile una diretta streaming nella sezione Eventi & Presentazioni del sito web delle Relazioni con gli Investitori di CareDx.

CareDx (Nasdaq: CDNA), una empresa centrada en soluciones de salud para trasplantes, ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el miércoles 26 de febrero de 2025. La empresa llevará a cabo una conferencia telefónica a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día. Las partes interesadas pueden acceder a la llamada mediante teléfono marcando 1-800-267-6316 (nacional) o 1-203-518-9783 (internacional) con ID de Conferencia: CareDx. También estará disponible una transmisión web a través de la sección de Eventos y Presentaciones en el sitio web de Relaciones con Inversores de CareDx.

CareDx (Nasdaq: CDNA), 이식 의료 솔루션에 집중하는 회사가 2024년 4분기 및 전체 연도 재무 결과를 2025년 2월 26일 수요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시 기준 오후 1시 30분 / 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 개최할 예정입니다. 관심 있는 분들은 1-800-267-6316 (국내) 또는 1-203-518-9783 (국제)로 전화를 걸어 회의 ID: CareDx를 사용하여 전화를 통해 참여할 수 있습니다. CareDx의 투자자 관계 웹사이트의 이벤트 및 발표 섹션을 통해 웹캐스트도 이용할 수 있습니다.

CareDx (Nasdaq: CDNA), une entreprise axée sur des solutions de santé pour les transplantations, a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 après la fermeture du marché le mercredi 26 février 2025. L'entreprise animera une conférence téléphonique le même jour à 13h30 heure du Pacifique / 16h30 heure de l'Est. Les parties intéressées peuvent accéder à l'appel par téléphone en composant le 1-800-267-6316 (national) ou le 1-203-518-9783 (international) avec l'ID de conférence : CareDx. Un webinaire sera également disponible dans la section Événements et Présentations du site web des Relations Investisseurs de CareDx.

CareDx (Nasdaq: CDNA), ein Unternehmen, das sich auf Transplantationsgesundheitslösungen spezialisiert hat, hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 nach Marktabschluss am Mittwoch, den 26. Februar 2025, veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifische Zeit / 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten. Interessierte Parteien können die Konferenz per Telefon unter 1-800-267-6316 (national) oder 1-203-518-9783 (international) mit der Konferenz-ID: CareDx erreichen. Ein Webcast wird ebenfalls über den Abschnitt Veranstaltungen & Präsentationen auf der Investor Relations-Website von CareDx verfügbar sein.

Positive
  • None.
Negative
  • None.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CareDx, Inc.

Investor Relations

Caroline Corner

investor@caredx.com

Source: CareDx, Inc.

FAQ

When will CareDx (CDNA) report Q4 and full year 2024 earnings?

CareDx will report Q4 and full year 2024 financial results after market close on Wednesday, February 26, 2025.

How can investors join CareDx's Q4 2024 earnings call?

Investors can join by dialing 1-800-267-6316 (domestic) or 1-203-518-9783 (international) with Conference ID: CareDx, or via webcast on the company's investor relations website.

What time is CareDx's Q4 2024 earnings conference call?

The conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on February 26, 2025.

Where can I access the webcast for CareDx's Q4 2024 earnings call?

The webcast can be accessed through the Events & Presentations section of CareDx's Investor Relations website at investors.caredx.com.

Caredx

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

1.25B
51.60M
3.78%
95.99%
8.18%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE